Spots Global Cancer Trial Database for organoids
Every month we try and update this database with for organoids cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer | NCT06155305 | Organoids Breast Cancer Neoadjuvant Che... | Biopsy | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. | NCT03500068 | Carcinoma, Panc... | biopsies & bloo... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Breast Cancer Subtype Characterization Through Patient's Derived Organoids. | NCT06315868 | Breast Cancer Organoids | 18 Years - 70 Years | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||
| Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers | NCT06435689 | Colon Cancer Peritoneal Carc... | Sampling | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Breast Cancer Subtype Characterization Through Patient's Derived Organoids. | NCT06315868 | Breast Cancer Organoids | 18 Years - 70 Years | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||
| Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC | NCT05332925 | Lung Cancer NSCLC NSCLC Stage IV | Standard of car... | 18 Years - 110 Years | University of Kansas Medical Center | |
| Using QPOP to Predict Treatment for Sarcomas and Melanomas | NCT04986748 | Sarcoma Melanoma | 21 Years - 99 Years | National Cancer Centre, Singapore | ||
| Breast Cancer Subtype Characterization Through Patient's Derived Organoids. | NCT06315868 | Breast Cancer Organoids | 18 Years - 70 Years | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | ||
| Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE) | NCT04279509 | Organoids HNSCC Epithelial Ovar... Colorectal Canc... | Tumor Core Biop... Blood sampling | 21 Years - 99 Years | National University Hospital, Singapore | |
| High Throughput Screening Device Based on 3D Nano-matrices and 3D Tumors With Functional Vascularization | NCT04826913 | NSCLC | Organoids | 18 Years - | University Hospital, Strasbourg, France | |
| Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma | NCT05644743 | Organoids Intrahepatic Ch... | gemcitabine + c... | 18 Years - 80 Years | Eastern Hepatobiliary Surgery Hospital | |
| Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma | NCT05644743 | Organoids Intrahepatic Ch... | gemcitabine + c... | 18 Years - 80 Years | Eastern Hepatobiliary Surgery Hospital | |
| Prospective Primary Human Lungcancer Organoids to Predict Treatment Response | NCT04859166 | Lung Cancer | Organoids | - | Maastricht Radiation Oncology | |
| Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Patient-derived Organoids and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC) | NCT06405230 | Lung Cancer, No... | Pembrolizumab Dostarlimab Pemetrexed+ (ca... | 30 Years - | GlaxoSmithKline | |
| Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. | NCT03500068 | Carcinoma, Panc... | biopsies & bloo... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer | NCT03577808 | Organoids Rectal Cancer Chemoradiation | Biopsy | 18 Years - 75 Years | Fudan University | |
| Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. | NCT03500068 | Carcinoma, Panc... | biopsies & bloo... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| High Throughput Screening Device Based on 3D Nano-matrices and 3D Tumors With Functional Vascularization | NCT04826913 | NSCLC | Organoids | 18 Years - | University Hospital, Strasbourg, France | |
| Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers | NCT06435689 | Colon Cancer Peritoneal Carc... | Sampling | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Patient-derived-organoid (PDO) Guided Versus Conventional Therapy for Advanced Inoperable Abdominal Tumors | NCT05378048 | Organoids | PDO-guided trea... standard of car... | 18 Years - 100 Years | Chinese University of Hong Kong | |
| Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids | NCT04555473 | Organoids Epithelial Ovar... | Tumor biopsy | 18 Years - 75 Years | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
